Travere Therapeutics to Present Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including two late-breaking oral presentations, at the upcoming American Society of Nephrology (ASN) Kidney Week 2023 in Philadelphia, PA, November 2-5, 2023.